Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[Increased TGF-? as a mechanism of acquired resistance to the anti-EGFR inhibitor cetuximab through EGFR-MET interaction and activation of MET signaling in colon cancer cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP731145.RAdGQEUr8AFfZ6zn4_eXZPckGGf7rFZAQ4Qsej6foCwi8130_assertion description "[Increased TGF-? as a mechanism of acquired resistance to the anti-EGFR inhibitor cetuximab through EGFR-MET interaction and activation of MET signaling in colon cancer cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP731145.RAdGQEUr8AFfZ6zn4_eXZPckGGf7rFZAQ4Qsej6foCwi8130_provenance.
• NP731537.RAYeJexrDb9Yj3uJDrggXp3Gxnax-wz1yi748sbYyxSak130_assertion description "[Increased TGF-? as a mechanism of acquired resistance to the anti-EGFR inhibitor cetuximab through EGFR-MET interaction and activation of MET signaling in colon cancer cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP731537.RAYeJexrDb9Yj3uJDrggXp3Gxnax-wz1yi748sbYyxSak130_provenance.
• NP802778.RAT1O2p7WJWMLPNHqI1MS34Ay43XQKekM5LHCpNLROYRk130_assertion description "[Increased TGF-? as a mechanism of acquired resistance to the anti-EGFR inhibitor cetuximab through EGFR-MET interaction and activation of MET signaling in colon cancer cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP802778.RAT1O2p7WJWMLPNHqI1MS34Ay43XQKekM5LHCpNLROYRk130_provenance.
• assertion description "[Increased TGF-? as a mechanism of acquired resistance to the anti-EGFR inhibitor cetuximab through EGFR-MET interaction and activation of MET signaling in colon cancer cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Increased TGF-? as a mechanism of acquired resistance to the anti-EGFR inhibitor cetuximab through EGFR-MET interaction and activation of MET signaling in colon cancer cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Increased TGF-? as a mechanism of acquired resistance to the anti-EGFR inhibitor cetuximab through EGFR-MET interaction and activation of MET signaling in colon cancer cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Increased TGF-? as a mechanism of acquired resistance to the anti-EGFR inhibitor cetuximab through EGFR-MET interaction and activation of MET signaling in colon cancer cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Increased TGF-? as a mechanism of acquired resistance to the anti-EGFR inhibitor cetuximab through EGFR-MET interaction and activation of MET signaling in colon cancer cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Increased TGF-? as a mechanism of acquired resistance to the anti-EGFR inhibitor cetuximab through EGFR-MET interaction and activation of MET signaling in colon cancer cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP1118838.RAZ_rNInieQwFFi0b3bV0dV960X_YtDpmwKPoAdgEPl30130_assertion description "[Increased TGF-? as a mechanism of acquired resistance to the anti-EGFR inhibitor cetuximab through EGFR-MET interaction and activation of MET signaling in colon cancer cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1118838.RAZ_rNInieQwFFi0b3bV0dV960X_YtDpmwKPoAdgEPl30130_provenance.
• NP1118835.RAsP8kvHsOM2hFaoygp-S92BnYDfGPMWAeatTb1yKyA04130_assertion description "[Increased TGF-? as a mechanism of acquired resistance to the anti-EGFR inhibitor cetuximab through EGFR-MET interaction and activation of MET signaling in colon cancer cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1118835.RAsP8kvHsOM2hFaoygp-S92BnYDfGPMWAeatTb1yKyA04130_provenance.
• NP1118840.RAiXPL55_BeiTXwGJ_YUAPS1HhpB0I5ZgPDuVv_ANip_o130_assertion description "[Increased TGF-? as a mechanism of acquired resistance to the anti-EGFR inhibitor cetuximab through EGFR-MET interaction and activation of MET signaling in colon cancer cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1118840.RAiXPL55_BeiTXwGJ_YUAPS1HhpB0I5ZgPDuVv_ANip_o130_provenance.
• NP1118844.RAp85LmMGgaDpZVWAYdHfwT-B3RYi2LCflONuJWwoT9jI130_assertion description "[Increased TGF-? as a mechanism of acquired resistance to the anti-EGFR inhibitor cetuximab through EGFR-MET interaction and activation of MET signaling in colon cancer cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1118844.RAp85LmMGgaDpZVWAYdHfwT-B3RYi2LCflONuJWwoT9jI130_provenance.
• NP1118847.RAoDekGIJrpN1ChvTxVjE66dY3d6BXbL7zmhlRLPb1DxQ130_assertion description "[Increased TGF-? as a mechanism of acquired resistance to the anti-EGFR inhibitor cetuximab through EGFR-MET interaction and activation of MET signaling in colon cancer cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1118847.RAoDekGIJrpN1ChvTxVjE66dY3d6BXbL7zmhlRLPb1DxQ130_provenance.
• NP554383.RAtnoi33-h6Y6C0h6LGyd7eGiaVFoFTw5ghvSFVO1Nrsc130_assertion description "[Increased TGF-? as a mechanism of acquired resistance to the anti-EGFR inhibitor cetuximab through EGFR-MET interaction and activation of MET signaling in colon cancer cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP554383.RAtnoi33-h6Y6C0h6LGyd7eGiaVFoFTw5ghvSFVO1Nrsc130_provenance.
• NP553886.RA9vSlthLKsmTvcwDHmF7cnUZKlQZurSkuRokd2AgcJS4130_assertion description "[Increased TGF-? as a mechanism of acquired resistance to the anti-EGFR inhibitor cetuximab through EGFR-MET interaction and activation of MET signaling in colon cancer cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP553886.RA9vSlthLKsmTvcwDHmF7cnUZKlQZurSkuRokd2AgcJS4130_provenance.
• NP945721.RAF3odLGx1vjvPqklK5mqFXr-4saViWCLs5qCQl5ktd8I130_assertion description "[Increased TGF-? as a mechanism of acquired resistance to the anti-EGFR inhibitor cetuximab through EGFR-MET interaction and activation of MET signaling in colon cancer cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP945721.RAF3odLGx1vjvPqklK5mqFXr-4saViWCLs5qCQl5ktd8I130_provenance.
• NP946056.RAFXq34wZ1WwK-cTjmo8NtewZjWXuyEhT3F0Z49P7Nnfo130_assertion description "[Increased TGF-? as a mechanism of acquired resistance to the anti-EGFR inhibitor cetuximab through EGFR-MET interaction and activation of MET signaling in colon cancer cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP946056.RAFXq34wZ1WwK-cTjmo8NtewZjWXuyEhT3F0Z49P7Nnfo130_provenance.
• NP1118843.RAHtklk3m06c3zEht128FNeMCOIRQ8tqISjOk5YSF-6ro130_assertion description "[Increased TGF-? as a mechanism of acquired resistance to the anti-EGFR inhibitor cetuximab through EGFR-MET interaction and activation of MET signaling in colon cancer cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1118843.RAHtklk3m06c3zEht128FNeMCOIRQ8tqISjOk5YSF-6ro130_provenance.
• NP803113.RA-EJ4ytvDYRj-pKFSLRSbsbguwUMSfuaNZwlxTjhAD3A130_assertion description "[Increased TGF-? as a mechanism of acquired resistance to the anti-EGFR inhibitor cetuximab through EGFR-MET interaction and activation of MET signaling in colon cancer cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP803113.RA-EJ4ytvDYRj-pKFSLRSbsbguwUMSfuaNZwlxTjhAD3A130_provenance.
• NP1118848.RA2GmTPQBaAP4mPy803vdABr-RfeI7JBfk1ny7wqN9AYg130_assertion description "[Increased TGF-? as a mechanism of acquired resistance to the anti-EGFR inhibitor cetuximab through EGFR-MET interaction and activation of MET signaling in colon cancer cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1118848.RA2GmTPQBaAP4mPy803vdABr-RfeI7JBfk1ny7wqN9AYg130_provenance.
• NP1118849.RA0-VrmIZLnIWSH8TUqNR4Ck9nUBtCSFRhrNEJklJSwHs130_assertion description "[Increased TGF-? as a mechanism of acquired resistance to the anti-EGFR inhibitor cetuximab through EGFR-MET interaction and activation of MET signaling in colon cancer cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1118849.RA0-VrmIZLnIWSH8TUqNR4Ck9nUBtCSFRhrNEJklJSwHs130_provenance.